Osteoporosis therapies in 2014

Area of Science:

• Bone biology and metabolic disorders
• Public health and epidemiology
• Geriatric medicine

Background:

• Osteoporosis is a systemic skeletal disorder defined by low bone mass and deteriorating bone tissue.
• This condition increases bone fragility, leading to a higher susceptibility to fractures.
• Fractures associated with osteoporosis result in substantial morbidity, mortality, and economic burdens.

Purpose of the Study:

• To review current therapeutic strategies for osteoporosis.
• To explore novel and emerging treatments for osteoporosis.
• To highlight the gap in osteoporosis evaluation and treatment post-fracture.

Main Methods:

• Comprehensive literature search of existing and emerging osteoporosis therapies.
• Analysis of clinical trial data and epidemiological studies.
• Synthesis of information on pharmacological and non-pharmacological interventions.

Main Results:

• Established treatments include bisphosphonates, denosumab, and teriparatide.
• Emerging therapies focus on anabolic agents and bone-modifying drugs.
• Significant underdiagnosis and undertreatment of osteoporosis following fragility fractures persist.

Conclusions:

• Effective management of osteoporosis requires addressing both existing treatments and novel therapeutic avenues.
• Improving the evaluation and treatment rates post-fracture is crucial for mitigating the impact of osteoporosis.
• Continued research into new therapies is essential for enhancing bone health and reducing fracture risk.